AHCA/NCAL: New COVID-19 Vaccine Approved for Use
On September 11, the U.S. Food and Drug Administration approved for emergency use updated COVID-19 vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc. These new vaccines are formulated to target current, more closely circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death.
On September 12, the Center for Disease Prevention and Control’s (CDC) Advisory Committee on Immunization Practices met to provide review the evidence and provide recommendations regarding use of these approved vaccines. The CDC recommends that if you have not received a COVID-19 vaccine in the past 2 months, to get the newly updated COVID-19 vaccine.
Additional Updates
“Your Top-Line” Edition on Proposed Minimum Staffing Available: A special edition of the 2023-Q3 Your Top-Line was published on LTC Trend Tracker that contains detailed information on how your center performs relative to the proposed federal minimum staffing requirements. Read More
VOTE FOR MARK TODAY!: AHCA/NCAL President & CEO Mark Parkinson has been named a finalist for Modern Healthcare’s 100 Most Influential People in Healthcare. Vote for Mark by TODAY, SEPTEMBER 18. Read More
Recording Now Available! AHCA Member Webinar: How to Submit Comments in Response to the CMS Minimum Staffing Proposal
Access the Recording
NYSHFA | NYSCAL CONTACTS:
Lisa Volk, RN, B.P.S., LNHA
Director, Clinical & Quality Services
518-462-4800 x15
Tarrah Quinlan, RN, BSN
Director of Education Program Development and Member Operations
518-462-4800 x20
